ArQule, Inc. - Press Releases

ArQule, Inc. to Present at Oppenheimer 22nd Annual Healthcare Conference
Dec 6, 2011

8.1 KB

WOBURN, Mass.--(BUSINESS WIRE)-- ArQule, Inc. (Nasdaq: ARQL) today announced that the Company will present at the Oppenheimer 22nd Annual Healthcare Conference on December 13, 2011 at 10:15 a.m. The presentation will be web cast and may be accessed through the investor relations section of the Company's ...

Daiichi Sankyo To License ARQ 092 from ArQule, the First New Compound Resulting from the Companies' Joint AKIP Research Collaboration
Nov 10, 2011

13.1 KB

ARQ 092 Will Soon Enter Phase 1 Clinical Trial WOBURN, Mass. & TOKYO--(BUSINESS WIRE)-- ArQule, Inc. (NASDAQ: ARQL) and Daiichi Sankyo, Co. Ltd. (TSE 4568) announced today the execution of a license agreement for the development of a new AKT inhibitor called ARQ 092, the first compound to em...

ArQule to Report Third Quarter 2011 Financial Results on November 10, 2011
Nov 3, 2011

8.8 KB

WOBURN, Mass.--(BUSINESS WIRE)-- ArQule, Inc. (NASDAQ: ARQL) today announced that it will report its financial results for the third quarter of 2011 in a press release to be issued on Thursday, November 10, 2011 at 7:00 a.m. eastern time. The Company will host a conference call at 9:00 a.m. eastern time that day ...

ArQule, Inc. to Present at Stifel Nicolaus 2011 Global Healthcare Conference
Sep 1, 2011

8.3 KB

WOBURN, Mass.--(BUSINESS WIRE)-- ArQule, Inc. (Nasdaq: ARQL) today announced that the Company will present at the Stifel Nicolaus 2011 Global Healthcare Conference on Thursday, September 8, 2011 at 9:45 a.m. The presentation will be web cast and may be accessed through the investor relations section of the ...

ArQule to Report Second Quarter 2011 Financial Results on August 4, 2011
Jul 28, 2011

8.9 KB

WOBURN, Mass.--(BUSINESS WIRE)-- ArQule, Inc. (NASDAQ: ARQL) today announced that it will report its financial results for the second quarter of 2011 in a press release to be issued on Thursday, August 4, 2011 at 7:00 a.m. eastern time. The Company will host a conference call at 9:00 a.m. eastern time that day ...

ArQule Comments on Presentations at ASCO 2011
May 31, 2011

14.9 KB

WOBURN, Mass.--(BUSINESS WIRE)-- ArQule, Inc. (Nasdaq: ARQL) today announced that the following presentations of clinical data for tivantinib (ARQ 197), an oral, selective inhibitor of the c-MET receptor tyrosine kinase, and for ARQ 621, an inhibitor of the Eg5 kinesin motor protein, will take place at t...

ArQule to Report First Quarter 2011 Financial Results on May 5, 2011
Apr 28, 2011

9.0 KB

WOBURN, Mass.--(BUSINESS WIRE)-- ArQule, Inc. (NASDAQ: ARQL) today announced that it will report its financial results for the first quarter of 2011 in a press release to be issued on Thursday, May 5, 2011 at 7:00 a.m. eastern time. The Company will host a conference call at 9:00 a.m. eastern time that day to ...

ArQule, Inc. to Present at Future Leaders in the Biotech Industry Conference
Apr 11, 2011

8.5 KB

WOBURN, Mass.--(BUSINESS WIRE)-- ArQule, Inc. (Nasdaq: ARQL) today announced that the Company will present at the 18th Annual Future Leaders in the Biotech Industry Conference on Friday, April 15, 2011 at 2:30 p.m. The presentation will be web cast and may be accessed through the investor relations secti...

ArQule, Inc. to Present at Needham and Leerink Swann Conferences
Mar 30, 2011

8.6 KB

WOBURN, Mass.--(BUSINESS WIRE)-- ArQule, Inc. (Nasdaq: ARQL) today announced that the Company will present at the 10th Annual Needham Healthcare Conference on Wednesday, April 6, 2011 at 9:20 a.m. eastern time, and at the Leerink Swann Cancer Roundtable Conference on Thursday, April 7, 2011 at 11:00 a.m....

ArQule, Inc. Announces Departure of Board Member
Feb 28, 2011

11.0 KB

WOBURN, Mass.--(BUSINESS WIRE)-- ArQule, Inc. (Nasdaq: ARQL) today announced that Dr. Nancy Simonian has tendered her resignation as a director of the Company effective on March 31, 2011. “I am proud of the progress ArQule has made during the past several years,” said Dr. Simonian. “The C...